NF-κB signaling in osteoarthritis: integrating mechanical stress, innate immunity, and cartilage degeneration
By
Peng Wan
Yimin Zheng
June 5, 2026
Clinical Scorecard: The Role of NF-κB Signaling in Osteoarthritis: A Comprehensive Look at Mechanical Stress, Innate Immune Responses, and Cartilage Deterioration
At a Glance
Category Detail
Condition Osteoarthritis (OA) is a complex, whole-joint disease characterized by inflammation and dysregulated mechanotransduction. Key Mechanisms NF-κB signaling integrates mechanical stress, innate immune activation, and metabolic inflammation, influencing joint degeneration. Target Population Aging populations with degenerative joint disorders, particularly those with chronic inflammation. Care Setting Clinical settings focusing on joint health, inflammatory diseases, and patient stratification.
Key Highlights
NF-κB is a crucial integrative signaling node in OA pathogenesis, influenced by upstream stimuli. Context-dependent NF-κB signaling shapes cartilage matrix remodeling, chondrocyte stress responses, and immune microenvironment changes in OA. Emerging therapeutic strategies target NF-κB networks for precision treatment, emphasizing mechanism-based patient stratification. Guideline-Based Recommendations
Diagnosis
Recognize OA as a complex, whole-joint disease characterized by inflammation and tissue remodeling. Management
Consider targeting NF-κB signaling pathways in treatment strategies, including specific pharmacological agents. Monitoring & Follow-up
Assess the impact of mechanical stress and inflammation on joint health through imaging and biomarkers. Risks
Be aware of the interplay between degenerative and inflammatory processes in OA, particularly in aging populations. Patient & Prescribing Data
Patients with osteoarthritis, particularly in aging demographics.
Mechanism-based stratification may enhance treatment efficacy.
Clinical Best Practices
Implement network-oriented combination strategies in OA management, such as combining anti-inflammatory and anabolic agents. Monitor the effects of upstream stimuli on NF-κB activation using biomarkers and patient-reported outcomes. Related Resources & Content
